UrFU patent on chemical ranked among top 100 best Russian inventions
The certificate is held by the collective staff of the Ural Branch of the Russian Academy of Sciences and the Ural Federal University Chemical Technology Institute, led by Oleg Chupakhina, an academic in the Department of Organic Chemistry and Russian Academy of Sciences.
The patent pertains to aminopropylmorpholine and 2-arylthiazol-4--hydrobromides having anti-platelet action--a synthesized compound that can be used in treating various cardiovascular diseases, including myocardial infarction and thrombotic stroke.
Dmitry Shulgin, the director for the Center for Intellectual Property UrFU, said the patent marks the first occasion that the university has been included in the rating.
The university has made the creation of new drugs based on compounds a priority for university researchers.
The selection of the best inventions in Russia has been conducted annually since 2007. One of the main criteria is the compliance with the priority areas of science, technology and engineering in the Russian Federation and the list of critical technologies of the Russian Federation. Other key areas are the technological re-equipment of the nuclear, aerospace, aviation industry and certain sectors of the defense industry and other key high-tech areas of the economy in the area of state responsibility.
- Ural Airlines modifies rewards program
- Exhibition to celebrate Tchaikovsky's birthday
- Ural State Academy of Architecture and Arts hosts first StartUp Design Week
- URFU hosts annual natural history festival
- Robocenter added to map of important robotics centers
- Sverdlovsk housing market prices increase
- Volschansk Mechanical Plant expanding product range
- Sverdlovsk Regional Entrepreneurship Support Fund to accept applications for CMEF
- Over 4,500 residents have already lost jobs this year in Sverdlovsk
- USMU accepting Global Education program applicants